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Abstract
© 2016  American  Association  for  Cancer  Research.Bone  metastasis  is  a  leading  cause
ofmorbidity andmortality in prostate cancer.While cancer stem-like cells have been implicated
as  a  cell  of  origin  for  prostate  cancer  metastasis,  the  pathways  that  enable  metastatic
development at distal  sites remain largely unknown. In this study, we illuminate pathways
relevant  to  bone metastasis  in  this  disease.  We observed that  cyclin  A1 (CCNA1)  protein
expression was relatively higher in prostate cancer metastatic lesions in lymph node, lung, and
bone/bone marrow. In both primary and metastatic  tissues,  cyclin A1 expression was also
correlated with aromatase (CYP19A1), a key enzyme that directly regulates the local balance of
androgens to estrogens. Cyclin A1 overexpression in the stem-like ALDHhigh subpopulation of
PC3M cells,  one model of prostate cancer, enabled bonemarrow integration and metastatic
growth. Further, cells obtained from bone marrow metastatic lesions displayed self-renewal
capability in colonyforming assays. In the bone marrow, cyclin A1 and aromatase enhanced
local  bonemarrow-releasing  factors,  including  androgen  receptor,  estrogen
andmatrixmetalloproteinase MMP9 and promoted the metastatic  growth of  prostate cancer
cells.  Moreover,  ALDHhigh tumor  cells  expressing elevated levels  of  aromatase stimulated
tumor/host estrogen production and acquired a growth advantage in the presence of host bone
marrow cells. Overall, these findings suggest that local production of steroids and MMPs in the
bone marrow may provide a suitable microenvironment for ALDHhigh prostate cancer cells to
establish  metastatic  growths,  offering  new  approaches  to  therapeutically  target  bone
metastases.  Cancer  Res;  76(8);  2453-64
http://dx.doi.org/10.1158/0008-5472.CAN-15-2340
